Observational Study on CML Patients in Any Phase of the Disease Treated With Ponatinib (Iclusig®)
Completed
- Conditions
- Chronic Myeloid Leukemia
- First Posted Date
- 2019-08-07
- Last Posted Date
- 2023-09-28
- Lead Sponsor
- Incyte BioSciences France
- Target Recruit Count
- 120
- Registration Number
- NCT04048564
- Locations
- 🇫🇷
Hopital Bicetre, Le Kremlin-Bicêtre, France
🇫🇷CH De Libourne, Libourne, France
🇫🇷CHRU De Lille - Hôpital Huriez, Lille Cedex, France
© Copyright 2025. All Rights Reserved by MedPath